当前位置:首页 - 行情中心 - 宏源药业(301246) - 财务分析 - 现金流量表

宏源药业

(301246)

  

流通市值:36.79亿  总市值:61.80亿
流通股本:2.38亿   总股本:4.00亿

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,315,844,280.5903,889,852.05259,322,027.831,023,470,542.97
  收到的税费返还8,048,685.423,616,759.853,238,494.3724,931,822.6
  收到其他与经营活动有关的现金12,894,287.875,518,917.46,796,891.4371,221,535.15
  经营活动现金流入小计1,336,787,253.79913,025,529.3269,357,413.631,119,623,900.72
  购买商品、接受劳务支付的现金870,331,182.96603,690,634.05137,778,866.34956,127,643.01
  支付给职工以及为职工支付的现金180,809,316.37126,899,741.8271,352,928.2219,961,860.47
  支付的各项税费102,586,139.7987,603,464.732,158,716.954,268,753.73
  支付其他与经营活动有关的现金72,166,438.6755,314,908.3338,558,415.0774,227,669.65
  经营活动现金流出小计1,225,893,077.79873,508,748.9279,848,926.511,304,585,926.86
  经营活动产生的现金流量净额110,894,17639,516,780.4-10,491,512.88-184,962,026.14
二、投资活动产生的现金流量:
  收回投资收到的现金3,150,043,793.841,787,816,190.42431,901,018.775,387,349,572.35
  取得投资收益收到的现金12,374,722.812,300,000--
  处置固定资产、无形资产和其他长期资产收回的现金净额1,989,517.82952,457.52473,183.722,114,836.97
  投资活动现金流入小计3,164,408,034.461,801,068,647.94432,374,202.495,389,464,409.32
  购建固定资产、无形资产和其他长期资产支付的现金233,582,039.7144,208,215.2657,100,870.27156,093,034.64
  投资支付的现金2,967,252,0001,895,961,828.76573,900,0005,474,000,000
  投资活动现金流出小计3,200,834,039.72,040,170,044.02631,000,870.275,630,093,034.64
  投资活动产生的现金流量净额-36,426,005.24-239,101,396.08-198,626,667.78-240,628,625.32
三、筹资活动产生的现金流量:
  取得借款收到的现金246,188,382.11220,641,422.4981,750,657.99504,553,476.5
  收到其他与筹资活动有关的现金---78,545,949.51
  筹资活动现金流入小计246,188,382.11220,641,422.4981,750,657.99583,099,426.01
  偿还债务支付的现金111,534,00098,757,00022,777,000307,914,000
  分配股利、利润或偿付利息支付的现金31,933,526.8127,284,167.13,905,516.4928,071,456.11
  支付其他与筹资活动有关的现金93,165,139.9987,688,369.2444,364,909.8715,766,629.19
  筹资活动现金流出小计236,632,666.8213,729,536.3471,047,426.36351,752,085.3
  筹资活动产生的现金流量净额9,555,715.316,911,886.1510,703,231.63231,347,340.71
四、汇率变动对现金及现金等价物的影响-3,261,073.33-2,365,081.33-1,500,551.33-354,941.99
五、现金及现金等价物净增加额80,762,812.74-195,037,810.86-199,915,500.36-194,598,252.74
  加:期初现金及现金等价物余额387,588,125.28387,588,125.28387,588,125.28582,186,378.02
  期末现金及现金等价物余额468,350,938.02192,550,314.42187,672,624.92387,588,125.28
补充资料:
  净利润-155,490,305.32-117,629,722.13
  资产减值准备-8,006,454.37-43,588,289.49
  固定资产和投资性房地产折旧-102,578,002.53-196,057,535.17
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-102,578,002.53-196,057,535.17
  无形资产摊销-2,771,688.62-5,457,289.29
  长期待摊费用摊销-1,246,885.9-2,686,474.6
  处置固定资产、无形资产和其他长期资产的损失-2,372,406.36--773,836.31
  固定资产报废损失-8,163,303.92-10,810,117.93
  公允价值变动损失-2,611,561.96--1,849,195.72
  财务费用-7,442,202.69-15,546,559.14
  投资损失--38,073,357--30,104,189.56
  递延所得税--259,650.77--2,297,864.27
  其中:递延所得税资产减少-292,653.87--2,408,607.98
    递延所得税负债增加--552,304.64-110,743.71
  存货的减少--60,614,273.92--54,126,972.35
  经营性应收项目的减少--269,490,112.44--579,111,126.27
  经营性应付项目的增加-116,667,173.68-79,469,220.22
  其他-118,636.4-11,084,844.81
  现金的期末余额-192,550,314.42-387,588,125.28
  减:现金的期初余额-387,588,125.28-582,186,378.02
  现金及现金等价物的净增加额--195,037,810.86--194,598,252.74
公告日期2026-10-282026-08-282026-04-292026-04-29
审计意见(境内)标准无保留意见
TOP↑